Edited by Peggy E. Chaudhry
Chapter 8: The challenge of curtailing the escalation of counterfeit pharmaceuticals
In this chapter, the discussion centers around the size and growth of illegitimate pharmaceuticals; the porous supply chain in both physical and virtual markets, which allows illicit traders to penetrate (or circumvent) the licit trade of pharmaceuticals; a succinct clarification of both formal organized crime groups and informal illicit traders fueling the supply; the evolution of agencies designed to govern and enforce this type of criminal activity; and an array of anti-counterfeiting tactics designed to curb this major problem.
You are not authenticated to view the full text of this chapter or article.
Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.
Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.
Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.